Cargando…

Efficacy and safety of baricitinib in patients with refractory alopecia areata

Detalles Bibliográficos
Autores principales: Wang, Yuqian, Liu, Taoming, Li, Sheng, Tang, Shunli, Lin, Peiyi, Ding, Yuwei, Sun, Qingmiao, Zhu, Dingxian, Qiao, Jianjun, Fang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078533/
https://www.ncbi.nlm.nih.gov/pubmed/36124361
http://dx.doi.org/10.1111/dth.15845
_version_ 1785020541447438336
author Wang, Yuqian
Liu, Taoming
Li, Sheng
Tang, Shunli
Lin, Peiyi
Ding, Yuwei
Sun, Qingmiao
Zhu, Dingxian
Qiao, Jianjun
Fang, Hong
author_facet Wang, Yuqian
Liu, Taoming
Li, Sheng
Tang, Shunli
Lin, Peiyi
Ding, Yuwei
Sun, Qingmiao
Zhu, Dingxian
Qiao, Jianjun
Fang, Hong
author_sort Wang, Yuqian
collection PubMed
description
format Online
Article
Text
id pubmed-10078533
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100785332023-04-07 Efficacy and safety of baricitinib in patients with refractory alopecia areata Wang, Yuqian Liu, Taoming Li, Sheng Tang, Shunli Lin, Peiyi Ding, Yuwei Sun, Qingmiao Zhu, Dingxian Qiao, Jianjun Fang, Hong Dermatol Ther Letters John Wiley & Sons, Inc. 2022-10-18 2022-12 /pmc/articles/PMC10078533/ /pubmed/36124361 http://dx.doi.org/10.1111/dth.15845 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters
Wang, Yuqian
Liu, Taoming
Li, Sheng
Tang, Shunli
Lin, Peiyi
Ding, Yuwei
Sun, Qingmiao
Zhu, Dingxian
Qiao, Jianjun
Fang, Hong
Efficacy and safety of baricitinib in patients with refractory alopecia areata
title Efficacy and safety of baricitinib in patients with refractory alopecia areata
title_full Efficacy and safety of baricitinib in patients with refractory alopecia areata
title_fullStr Efficacy and safety of baricitinib in patients with refractory alopecia areata
title_full_unstemmed Efficacy and safety of baricitinib in patients with refractory alopecia areata
title_short Efficacy and safety of baricitinib in patients with refractory alopecia areata
title_sort efficacy and safety of baricitinib in patients with refractory alopecia areata
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078533/
https://www.ncbi.nlm.nih.gov/pubmed/36124361
http://dx.doi.org/10.1111/dth.15845
work_keys_str_mv AT wangyuqian efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT liutaoming efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT lisheng efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT tangshunli efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT linpeiyi efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT dingyuwei efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT sunqingmiao efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT zhudingxian efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT qiaojianjun efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata
AT fanghong efficacyandsafetyofbaricitinibinpatientswithrefractoryalopeciaareata